Back to Intelligence
#pharmaceutical-costs
(2 articles)Risk & Disruption
ModerateMay 14, 2026Duopharma Warns of Rising Costs and Supply Chain Disruption Risk
Duopharma, a major Malaysian pharmaceutical manufacturer, has issued a forward-looking warning about escalating operational costs and potential supply chain disruptions even as the company delivered r
The Edge Malaysia#pharmaceutical-costs#supply-chain-disruption#cost-inflation
Trade Policy & Tariffs
High ImpactApr 25, 2026Pharma Industry Faces Tariff Pressure: Peer Survey Results
A peer survey of bio/pharma companies reveals growing concerns regarding tariffs and evolving trade policy, with widespread implications across the industry. Respondents indicate that trade barriers a
PharmTech.com#pharma-tariffs#trade-policy#drug-manufacturing